|
1
|
Scherpereel A, Astoul P, Baas P, Berghmans
T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin
C, Hillerdal G, et al: Guidelines of the European respiratory
society and the European society of thoracic surgeons for the
management of malignant pleural mesothelioma. Eur Respir J.
35:479–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Santos FR: Membranous glomerulonephritis:
New insights in pathophysiology and therapeutic approach. J Bras
Nefrol. 36:59–62. 2014.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schroeter NJ, Rushing DA, Parker JP and
Beltaos E: Minimal-change nephrotic syndrome associated with
malignant mesothelioma. Arch Intern Med. 146:1834–1836. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanaka S, Oda H, Satta H, Takizawa T,
Tochikubo O, Takagi N, Ishii M and Kaneko T: Nephrotic syndrome
associated with malignant mesothelioma. Nephron. 67:510–511. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dogan M, Ozal G, Savas B, Gungor M, Utkan
G, Yalcin B and Icli F: Malign peritoneal mesothelioma with
nephrotic syndrome. Bratisl Lek Listy. 113:43–45. 2012.PubMed/NCBI
|
|
6
|
Galesic K, Bozic B, Heinzl R,
ScukanecSpoljar M and Bozikov V: Pleural mesothelioma and
membranous nephropathy. Nephron. 84:71–74. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki S, Toyoshima M, Nihashi F, Tsukui
H, Baba S, Sugimura H and Suda T: An autopsy case of malignant
pleural mesothelioma associated with nephrotic syndrome. Intern
Med. 53:243–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bacchetta J, Ranchère D, Dijoud F and Droz
JP: Mesothelioma of the testis and nephrotic syndrome: A case
report. J Med Case Rep. 3:72482009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farmer CK and Goldsmith DJ: Nephrotic
syndrome and mesenteric infarction secondary to metastatic
mesothelioma. Postgrad Med J. 77:333–334. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
vanZandwijk N, Clarke C, Henderson D, Musk
AW, Fong K, Nowak A, Loneragan R, McCaughan B, Boyer M, Feigen M,
et al: Guidelines for the diagnosis and treatment of malignant
pleural mesothelioma. J Thorac Dis. 5:E254–E307. 2013.PubMed/NCBI
|
|
11
|
Vogelzang NJ, Rusthoven JJ, Symanowski J,
Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S,
Manegold C, et al: Phase III study of pemetrexed in combination
with cisplatin versus cisplatin alone in patients with malignant
pleural mesothelioma. J Clin Oncol. 21:2636–2644. 2003. View Article : Google Scholar : PubMed/NCBI
|
